Pfizer rose over 9% in premarket trading as its antiviral pill cut risk of severe COVID-19 by 89%<blockquote>辉瑞(Pfizer)在盘前交易中上涨超过9%,其抗病毒药物将严重COVID-19的风险降低了89%</blockquote>
A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug wa
Nvidia shares rose more than 2% to a new high<blockquote>英伟达股价涨超2%创新高</blockquote>
Wall Street will be looking for positivity from NVDA as it approaches its next earnings report date. This is expected to be November 17, 2021. In that report, analysts expect NVDA to post earnings of $1.11 per share. This would mark year-over-year growth of 52.05%. Our most recent consensus estimate is calling for quarterly revenue of $6.83 billion, up 44.46% from the year-ago period.NVDA's full-year Zacks Consensus Estimates are calling for earnings of $4.14 per share and revenue of $25.84 bill